USPTO to decide CRISPR/Cas9 dispute
Washington DC | 14 January 2016

The US Patent and Trademark Office (USPTO) has weighed in on a CRISPR/Cas9 technology dispute between two inventors.

The USPTO initiated an interference on 11 January between the Broad Institute of MIT and Harvard and the University of California, whose scientists both claim to be the inventors of the same CRISPR/Cas9 technology and have filed patent applications.

Judge Deborah Katz has been appointed to manage the interference.

Feng Zhang of the Broad Institute of MIT and Harvard and Jennifer Doudna of the University of California, both claim to have invented the technology, which relates to CRISPR-Cas9 gene editing in animal cells.

The America Invents Act changed the US patent system from first-to-invent to first-to-file.

Both inventors filed their patent applications prior to the act’s implementation. Doudna filed a patent application in May 2012, while Zhang filed his application in December 2012.

The parties have been instructed to file a list of motions to accompany their arguments, no later than 3 March.

Author: Tammy Facey



More IPPro Life Sciences | latest news
AstraZeneca enters China with Plendil
Hogan Lovells boosts capabilities in Japan
Morgan Lewis bags four from K&L Gates
Cobra and CPI enter £1.8 million project
Doctors Without Borders urges lower vaccine prices
IPPro Life Sciences
IPPRO ARCHIVES
BACK ISSUES ONLINE
COMPANY INFO
ABOUT US

THE TEAM


Copyright (C) 2013 Black Knight Media Ltd. All rights reserved. No reproduction without prior authorization